Q1 HIGHLIGHTS Strong first quarter sales, Acquisition of unique 3D rendering technology, Milestone for new technology platform reached...

Q4 HIGHLIGHTS Governmental grant for new pilot research project, in line with growth strategy. New Mammo 2 product successfully launched at RSNA. New product configuration for Ultrasound Point-of-Care...

Q3 HIGHLIGHTS Broadened Ultrasound product portfolio, Strengthened sales efforts in Russia, New academic collaboration in order to broaden offer for 3D Ultrasound...

Highlights: New major ultrasound customer signed, ContextVision wins important court ruling regarding patent litigation against Sapheneia...

Highlights: • Significant sales development • Europe strengthened position • 3D Ultrasound focus at RSNA in Chicago • Product upgrades for Ultrasound, XR, MRI and iRV Click to view Webcast Q4 2012

Highlights: • Significant development in the United States • Encouraging participation at ISOUG congress • Long term order with key customer signed Click to view Webcast Q2 2012

Highlights: • Sales increase 12 % • Significant ultrasound sales development • Important milestones reached within iRV and mammography • Web-based customer portal introduced • Ongoing litigation – first instance decision Click to view Webcast Q2 2012

Highlights: • Sales increase 15 % • Large customers broadening future commitment. • Increase of market share in XR • Government Contribution of 1.4 MSEK for mammography product development Click to view Webcast Q1 2012

Highlights: • Substantial sales growth
• Significant order for GOPiCE® US
• US PLUSViewTM first commercial delivery
• Very positive customer feedback at RSNA in Chicago Click to view Webcast Q4 2011

Highlights: • Mammo PLUSViewCAD into sales phase
• Second major customer starts to order GOPiCE® US
• First commercial order for our new modular ultrasound product range, US PLUSViewTM Click to view Webcast Q3 2011